Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer

[MEDPAGE TODAY]( Oncology Update Tuesday, June 18, 2024 [Two New Immunotherapy-Chemo Options Approved for Endometrial Cancer]( [Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL]( [Atezolizumab Consolidation Impresses in High-Risk DLBCL]( [New Standard of Care in High-Risk Acute Promyelocytic Leukemia?]( [PERSPECTIVES]( [I Tried to Protect My Mother From Dying in Pain. The Law Robbed Her of That Dignity.]( ADVERTISEMENT Exclusives & Features [Health System Eliminates Noncompetes for Primary Care Physicians]( [What to Know About Medetomidine and Drug Overdoses]( [Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.]( PURPOSE: We present a phase I/II first-in-human trial evaluating the safety and efficacy of 50 mg and 200 mg doses of linvoseltamab, a B-cell maturation antigen × CD3 bispecific antibody in... [READ MORE]( [An elevated rate of whole-genome duplications associated with carcinogen exposure in Black cancer patients]( In the United States, Black individuals have higher rates of cancer mortality than any other racial or ethnic group. The sources of these significant racial disparities are not fully understood, and... [READ MORE]( [Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors]( Background: Central nervous system (CNS) tumors lead to cancer-related mortality in children. Genetic ancestry-associated cancer prevalence and outcomes have been studied, but is limited. Methods: We... [READ MORE]( [Insulin resistance during androgen deprivation therapy in men with prostate cancer.]( BACKGROUND: Androgen deprivation therapy (ADT) in prostate cancer (PCa) has been associated with development of insulin resistance. However, the predominant site of insulin resistance remains... [READ MORE]( [Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience.]( BACKGROUND: Standard treatment options for patients with metastatic urothelial cancer (mUC) include systemic platinum-based chemotherapy, immunotherapy, antibody-drug-conjugates, and targeted... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-06-18&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011